Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
The collaboration between CORONA and Ferring will cater to patients across India
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma
Subscribe To Our Newsletter & Stay Updated
